Clinical Trial Update: Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nebulized salbutamol added to intravenous atropine and oxygen for organophosphate poisoning has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organophosphate Poisoning

Drugs mentioned

• Atropine (atropine)
• Salbutamol (Nebulized) (salbutamol)

Snippet

Sponsor: Sylhet M.A.G.Osmani Medical College | Conditions: Organophosphate Poisoning | Phase 3 | Status: COMPLETED